Max Healthcare Institute (MAXHEALTH.NS) Stock Price

Max Healthcare Institute Price

NSE·CLOSED
1,069.00INR-1.00 (-0.09 %)
Market closed

Over the last 6 years Max Healthcare Institute grew revenue by 26.8% annually, reaching 70.28 B INR. Earnings per share have grown at 76.2% per year over the last 5 years. For Max Healthcare Institute, the net margin of 15.3% is up versus -5.5% a few years ago. At today's price the dividend yield works out to roughly 0.14%. The payout ratio is around 14% of earnings. The dividend has grown at 22.5% per year over the past 2 years. The consensus 12-month price target for Max Healthcare Institute is 1,295.40 INR, about 21.2% above where the stock trades today. Of 25 analysts, 18 rate the stock a buy — an overall Buy consensus. The stock trades about 15% above its 52-week low.

Max Healthcare Institute stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Max Healthcare Institute over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Max Healthcare Institute stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Max Healthcare Institute's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Max Healthcare Institute Stock Price History
DateMax Healthcare Institute Price
8/10/20261,069.00 INR
8/7/20261,070.00 INR
8/6/20261,072.40 INR
8/5/20261,080.00 INR
8/4/20261,093.00 INR
7/31/20261,098.50 INR
7/30/20261,116.50 INR
7/28/20261,117.00 INR
7/24/20261,080.40 INR
7/23/20261,086.10 INR
7/22/20261,081.00 INR
7/21/20261,100.40 INR
7/20/20261,102.40 INR
7/17/20261,096.00 INR
7/15/20261,102.70 INR
7/14/20261,092.90 INR
7/13/20261,106.20 INR
7/10/20261,108.10 INR
7/9/20261,101.30 INR
7/8/20261,084.80 INR
7/7/20261,118.40 INR
7/6/20261,132.50 INR
7/3/20261,152.40 INR
7/2/20261,127.40 INR
7/1/20261,139.90 INR
6/30/20261,129.25 INR
6/29/20261,149.90 INR
6/25/20261,123.35 INR
6/24/20261,081.70 INR
6/23/20261,078.05 INR
6/22/20261,095.05 INR
6/19/20261,094.75 INR
6/18/20261,090.45 INR
6/17/20261,026.15 INR
6/16/20261,024.10 INR
6/15/20261,026.90 INR
6/12/20261,012.45 INR
6/11/20261,009.60 INR
6/10/20261,020.35 INR
6/9/20261,003.10 INR
6/8/20261,007.45 INR
6/5/2026977.25 INR
6/4/2026966.20 INR
6/3/2026965.55 INR
6/2/2026948.70 INR
6/1/2026938.45 INR
5/29/2026965.10 INR
5/27/2026993.45 INR
5/26/2026993.95 INR
5/25/20261,000.85 INR
5/22/20261,023.25 INR
5/21/20261,091.10 INR
5/20/20261,062.55 INR
5/19/20261,068.75 INR
5/18/20261,058.55 INR
5/15/20261,050.10 INR
5/14/20261,049.55 INR
5/13/20261,026.10 INR
5/12/20261,017.70 INR
5/11/20261,037.95 INR
5/8/20261,012.50 INR
5/7/20261,015.30 INR
5/6/20261,015.90 INR
5/5/20261,000.45 INR
5/4/20261,011.55 INR
5/1/2026993.05 INR
4/30/2026993.05 INR
4/29/20261,006.60 INR
4/28/20261,004.75 INR
4/27/20261,009.85 INR
4/24/2026999.40 INR
4/23/20261,006.75 INR
4/22/20261,005.35 INR
4/21/20261,020.25 INR
4/20/20261,011.35 INR
4/17/20261,007.65 INR
4/16/2026990.65 INR
4/15/2026990.05 INR
4/13/2026951.70 INR
4/10/2026953.35 INR
4/9/2026954.95 INR
4/8/2026941.15 INR
4/7/2026932.40 INR
4/6/2026931.60 INR
4/2/2026944.60 INR
4/1/2026958.90 INR
3/30/2026962.30 INR
3/27/2026975.10 INR
3/25/2026992.80 INR
3/24/2026966.50 INR
3/23/2026953.30 INR
3/20/2026962.00 INR
3/19/2026953.10 INR
3/18/2026979.80 INR
3/17/2026976.00 INR
3/16/2026967.00 INR
3/13/2026991.00 INR
3/12/20261,019.90 INR
3/11/20261,033.00 INR
3/10/20261,040.00 INR
3/9/20261,039.00 INR
3/6/20261,045.00 INR
3/5/20261,058.20 INR
2/27/20261,090.75 INR
2/26/20261,109.90 INR
2/25/20261,088.10 INR
2/24/20261,080.40 INR
2/23/20261,083.60 INR
2/20/20261,087.90 INR
2/19/20261,081.45 INR
2/18/20261,086.25 INR
2/17/20261,076.00 INR
2/16/20261,075.00 INR
2/13/20261,053.60 INR
2/12/20261,062.00 INR
2/11/20261,055.15 INR
2/10/20261,021.50 INR
2/9/20261,010.00 INR
2/6/20261,040.00 INR
2/5/20261,038.00 INR
2/4/20261,022.50 INR
2/3/20261,003.50 INR
2/2/2026958.10 INR
1/30/2026956.80 INR
1/29/2026952.60 INR
1/28/2026960.00 INR
1/27/2026975.50 INR
1/23/2026991.40 INR
1/22/2026998.80 INR
1/21/20261,006.00 INR
1/20/2026990.00 INR
1/19/20261,013.60 INR
1/16/20261,037.00 INR
1/14/20261,034.60 INR
1/13/20261,028.20 INR
1/12/20261,015.90 INR
1/9/20261,017.10 INR
1/8/20261,029.80 INR
1/7/20261,034.90 INR
1/6/20261,051.60 INR
1/5/20261,050.50 INR
1/2/20261,062.60 INR
1/1/20261,049.40 INR
12/31/20251,045.10 INR
12/30/20251,046.60 INR
12/29/20251,062.00 INR
12/26/20251,074.30 INR
12/24/20251,080.10 INR
12/23/20251,075.00 INR
12/22/20251,075.10 INR
12/19/20251,076.00 INR
12/18/20251,048.00 INR
12/17/20251,033.20 INR
12/16/20251,073.00 INR
12/15/20251,083.50 INR
12/12/20251,080.00 INR
12/11/20251,089.10 INR
12/10/20251,080.50 INR
12/9/20251,074.70 INR
12/8/20251,079.40 INR
12/5/20251,097.40 INR
12/4/20251,081.20 INR
12/3/20251,085.00 INR
12/2/20251,119.00 INR
12/1/20251,131.80 INR
11/28/20251,162.80 INR
11/27/20251,161.40 INR
11/26/20251,162.60 INR
11/25/20251,152.00 INR
11/24/20251,155.80 INR
11/21/20251,179.10 INR
11/20/20251,168.90 INR
11/19/20251,164.40 INR
11/18/20251,116.70 INR
11/17/20251,121.60 INR
11/14/20251,101.90 INR
11/13/20251,098.70 INR
11/12/20251,103.60 INR
11/11/20251,096.50 INR
11/10/20251,099.80 INR
11/7/20251,136.10 INR
11/6/20251,128.80 INR
11/4/20251,139.50 INR
11/3/20251,152.00 INR
10/31/20251,149.00 INR
10/30/20251,176.00 INR
10/29/20251,190.40 INR
10/28/20251,187.90 INR
10/27/20251,187.00 INR
10/24/20251,184.10 INR
10/23/20251,211.00 INR
10/21/20251,204.00 INR
10/20/20251,208.60 INR
10/17/20251,202.70 INR
10/16/20251,175.00 INR
10/15/20251,158.00 INR
10/14/20251,159.50 INR
10/13/20251,143.30 INR
10/10/20251,155.50 INR
10/9/20251,155.80 INR
10/8/20251,144.40 INR
10/7/20251,130.70 INR
10/6/20251,137.00 INR
10/3/20251,070.00 INR
10/1/20251,113.20 INR
9/30/20251,120.00 INR
9/29/20251,112.00 INR
9/26/20251,123.40 INR
9/25/20251,137.70 INR
9/24/20251,133.20 INR
9/23/20251,154.70 INR
9/22/20251,171.60 INR
9/19/20251,159.70 INR
9/18/20251,173.00 INR
9/17/20251,153.80 INR
9/16/20251,158.70 INR
9/15/20251,175.40 INR
9/12/20251,184.20 INR
9/11/20251,179.30 INR
9/10/20251,180.00 INR
9/9/20251,152.90 INR
9/8/20251,149.60 INR
9/5/20251,170.00 INR
9/4/20251,160.40 INR
9/3/20251,160.00 INR
9/2/20251,161.80 INR
9/1/20251,180.90 INR
8/29/20251,150.00 INR
8/28/20251,160.20 INR
8/26/20251,184.00 INR
8/25/20251,221.40 INR
8/22/20251,229.90 INR
8/21/20251,249.00 INR
8/20/20251,225.60 INR
8/19/20251,233.00 INR
8/18/20251,211.60 INR
8/14/20251,220.70 INR
8/13/20251,267.60 INR
8/12/20251,262.50 INR
Access this data via the Eulerpool API
Get Free API Key

Max Healthcare Institute Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
45.63 B INR
10.12 B INR
11.04 B INR
Jan 1, 2024
54.06 B INR
12.59 B INR
10.58 B INR
Jan 1, 2025
70.28 B INR
15.16 B INR
10.76 B INR
Jan 1, 2026 (e)
101.88 B INR
22.38 B INR
16.64 B INR
Jan 1, 2027 (e)
120.02 B INR
26.37 B INR
19.41 B INR
Jan 1, 2028 (e)
142.32 B INR
31.27 B INR
23.63 B INR
Jan 1, 2029 (e)
172.25 B INR
37.84 B INR
29.10 B INR
Jan 1, 2030 (e)
174.88 B INR
62.45 B INR
42.60 B INR

Max Healthcare Institute Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 12, 2026, 5:26 AM
 
REVENUEB INR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB INR
EBITB INR
EBIT MARGIN%
NET INCOMEB INR
NET INCOME GROWTH%
DIV.INR
DIV. GROWTH%
SHARESM
20192020202120222023202420252026e2027e2028e2029e2030e
16.9110.5925.0539.3145.6354.0670.28101.88120.02142.32172.25174.88
–-37.37136.5156.9716.0618.4930.0144.9617.8018.5821.031.53
75.6779.4874.2274.9378.2877.8777.3577.3577.3577.3577.3577.35
12.808.4218.5929.4635.7242.1054.3678.8092.83110.08133.23135.27
0.540.482.307.4010.1212.5915.1622.3826.3731.2737.8462.45
3.204.529.1818.8222.1723.2821.5721.9721.9721.9721.9735.71
-0.030.59-1.386.0511.0410.5810.7616.6419.4123.6329.1042.60
–-2,066.67-333.05-540.0082.40-4.161.7254.6816.6621.7323.1646.36
––––1.001.501.501.501.802.16––
–––––50.00––20.0020.00––
911.00911.00863.20969.38971.71975.46977.43977.43977.43977.43977.43977.43
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Max Healthcare Institute generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Max Healthcare Institute retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Max Healthcare Institute's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Max Healthcare Institute has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Max Healthcare Institute's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Max Healthcare Institute stock margins

The Max Healthcare Institute margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Max Healthcare Institute. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Max Healthcare Institute.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
74.22 %
9.18 %
-5.49 %
Jan 1, 2022
74.93 %
18.82 %
15.39 %
Jan 1, 2023
78.28 %
22.17 %
24.19 %
Jan 1, 2024
77.88 %
23.28 %
19.56 %
Jan 1, 2025
77.35 %
21.57 %
15.31 %
Jan 1, 2026 (e)
77.35 %
21.97 %
16.33 %
Jan 1, 2027 (e)
77.35 %
21.97 %
16.17 %
Jan 1, 2028 (e)
77.35 %
21.97 %
16.60 %

Max Healthcare Institute Stock Revenue, EBIT, Earnings per Share

The Max Healthcare Institute earnings per share therefore indicates how much revenue Max Healthcare Institute has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
29.02 INR
2.66 INR
-1.59 INR
Jan 1, 2022
40.56 INR
7.63 INR
6.24 INR
Jan 1, 2023
46.95 INR
10.41 INR
11.36 INR
Jan 1, 2024
55.42 INR
12.90 INR
10.84 INR
Jan 1, 2025
71.91 INR
15.51 INR
11.01 INR
Jan 1, 2026 (e)
104.24 INR
22.90 INR
17.03 INR
Jan 1, 2027 (e)
122.79 INR
26.97 INR
19.86 INR
Jan 1, 2028 (e)
145.61 INR
31.99 INR
24.18 INR

Max Healthcare Institute business model & stock analysis

Max Healthcare Institute Ltd is a healthcare company headquartered in New Delhi, India. The company was founded in 2000 and today has over 14 facilities throughout India. Max Healthcare operates in the private equity sector and has targeted the Philippines and the United Arab Emirates as market destinations. Max Healthcare's business model is focused on providing comprehensive healthcare worldwide through a wide range of services and products. Max Healthcare facilities offer a broad range of services including emergency medicine, cardiology, gastroenterology, neurology, oncology, ophthalmology, gynecology, and obstetrics. Additionally, they offer refresher courses for medical careers. The different divisions of Max Healthcare Institute include acute medicine, mother and child care, care management, and eHealth. Acute medicine operates fully equipped hospitals and emergency centers for emergency medicine. The mother and child care division includes pediatric units, pediatric intensive care units, and facilities for gynecology and obstetrics. The care management division provides a variety of services for health insurance providers, employers, and other healthcare providers. The eHealth division utilizes digital medical technology for improved healthcare possibilities through remote monitoring and training. In addition, Max Healthcare Institute has developed products such as medical devices for hospitals and neurophysiology products for clinical applications. Max Healthcare takes pride in being a leader in digital healthcare and offers customers access and control over their medical data through the Max MyHealth app. Max MyHealth provides real-time personal health records and the ability to share and store personal medical data. The business development of Max Healthcare Institute is an impressive example of how a company can grow and evolve. Over the past 20 years, Max Healthcare Institute has grown from a small company to one with over 14 facilities throughout India. They are proud to offer their patients world-class hospital beds, knowledge management, state-of-the-art medical technology, and recognized doctors and specialists. Max Healthcare Institute is also a significant player in the media in India and around the world. The company has received numerous awards for its operational excellence, hospitals, and pioneering role in digital healthcare. Max Healthcare takes pride in meeting a high standard in its healthcare services, comparable to the relatively high standards in other countries such as the United States, Europe, or Australia. Overall, Max Healthcare Institute Ltd has played a significant role in the healthcare industry in recent years. The company has developed a wide range of services and products to provide comprehensive healthcare to its customers. Max Healthcare has become one of the leading companies in the medical industry and continues to strive to provide its customers with the best healthcare services.

Max Healthcare Institute SWOT Analysis

Strengths

Max Healthcare Institute Ltd is a leading healthcare provider with a strong presence in the industry. It possesses several key strengths including an extensive network of hospitals and clinics, a highly skilled and experienced medical staff, and a reputation for delivering high-quality patient care. Additionally, Max Healthcare has a well-established brand image and a loyal customer base.

Weaknesses

Despite its strengths, Max Healthcare Institute Ltd also faces certain weaknesses. These may include limited geographic coverage compared to some competitors, potential challenges in maintaining affordable services for all segments of society, and dependency on third-party insurance providers for revenue generation.

Opportunities

Max Healthcare Institute Ltd has several opportunities for further growth and expansion. Firstly, it can explore new markets and regions by opening more healthcare facilities to cater to a larger customer base. Secondly, it can invest in advanced medical technologies and treatments to attract patients seeking specialized healthcare services. Lastly, there is potential for partnership with government bodies or private entities to provide healthcare solutions in underprivileged areas.

Threats

Max Healthcare Institute Ltd is not immune to threats in the competitive healthcare industry. External factors such as rapidly evolving medical technologies, changing regulatory frameworks, and increasing competition from both domestic and international players pose challenges. Additionally, any negative impact on the economy or changes in healthcare policies can also affect the company's operations and profitability.

Max Healthcare Institute Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Max Healthcare Institute historical P/E ratio, EBIT multiple, and P/S ratio

Max Healthcare Institute annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Max Healthcare Institute shares outstanding

The number of shares of Max Healthcare Institute was 977.43 M in 2025. This indicates how many shares Max Healthcare Institute is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
863.20 M Stocks
Jan 1, 2022
969.38 M Stocks
Jan 1, 2023
971.71 M Stocks
Jan 1, 2024
975.46 M Stocks
Jan 1, 2025
977.43 M Stocks
Jan 1, 2026 (e)
977.43 M Stocks
Jan 1, 2027 (e)
977.43 M Stocks
Jan 1, 2028 (e)
977.43 M Stocks

Max Healthcare Institute Dividend History

3 years of dividend payments

YearAnnual DividendYoY ChangePayments
20251.50INR 0.0%1×
Jul 4, 20251.50INR 0.0%1/1
20241.50INR↑ 50.0%1×
20231.00INR—1×

Max Healthcare Institute dividend history and estimates

In 2025, Max Healthcare Institute paid a dividend amounting to 1.50 INR. Dividend means that Max Healthcare Institute distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2023 (e)
0.00 INR
1.00 INR
Jan 1, 2024
1.50 INR
0.00 INR
Jan 1, 2025
1.50 INR
0.00 INR
Jan 1, 2026
1.50 INR
0.00 INR
Jan 1, 2027 (e)
0.00 INR
1.80 INR
Jan 1, 2028 (e)
0.00 INR
2.16 INR

Max Healthcare Institute dividend payout ratio

In 2025, Max Healthcare Institute had a payout ratio of 13.63%. The payout ratio indicates the percentage of the company's profits that Max Healthcare Institute distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
12.09 %
Jan 1, 2022
12.09 %
Jan 1, 2023
8.81 %
Jan 1, 2024
13.83 %
Jan 1, 2025
13.63 %
Jan 1, 2026 (e)
8.81 %
Jan 1, 2027 (e)
9.06 %
Jan 1, 2028 (e)
8.93 %

Current Max Healthcare Institute forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
1.55 %
Buy
72.00 % (18)
Hold
12.00 % (3)
Sell
16.00 % (4)
12M Price Target
1,295.40
Last Price
1,069.00
Currency
INR
12M Return Potential
21.18 %
LTM Return
0 %

Max Healthcare Institute Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
5/14/20243.29INR-18.85 BINR-2024 Q4
2/1/20243.53INR-16.86 BINR-2024 Q3

EESG©

Eulerpool ESG Scorecard© for the Max Healthcare Institute stock

98/100
99
Environment
99
Social
96
Governance
E

Environment

20
Scope 1 - Direct Emissions5,589
Scope 2 - Indirect emissions from purchased energy42,123
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions62,973
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees45.967
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Max Healthcare Institute shareholder structure

% Name
23.60457%
Soi (Abhay)
Soi (Abhay)
4.42172%
GIC Private Limited
GIC Private Limited
2.78365%
NPS Trust
NPS Trust
2.62394%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
2.57508%
SBI Funds Management Pvt. Ltd.
SBI Funds Management Pvt. Ltd.
2.35442%
Kotak Mahindra Asset Management Company Limited
Kotak Mahindra Asset Management Company Limited
...

Max Healthcare Institute Beneficial Ownership Filings (SEC 13D/G)

Free Float
71.8%
Float Shares
-
Shares Outstanding
-

Max Healthcare Institute Executives and Management Board

25 members · avg. age 62 · 12 % women

AS

Mr. Abhay Soi (51)

Executive Chairman of the Board, Managing Director · since 2019

295.19 M INR

Management

MK

Mr. Mradul Kaushik

Senior Director - Operations and Planning and Chief Operating Officer (Cluster 1) · since 2024

10.97 M INR
YS

Mr. Yogesh Sareen

Chief Financial Officer, Senior Director · since 2012

8.51 M INR
UG

Mr. Umesh Gupta

Chief Human Resources Officer, Senior Director - Human Resources

–
DA

Mr. Dhiraj Aroraa

Senior Vice President - Compliance Officer, Company Secretary

–
DK

Mr. D.N. Kumar

Senior Vice President - Infrastructure

–
SK

Mr. Sachin Kumar

Senior Vice President - Internal Audit

–

Board of Directors

ML

Mr. Mahendra Lodha (68)

Non-Executive Independent Director

5.60 M INR
AG

Ms. Amrita Gangotra (59)

Non-Executive Independent Director

5.50 M INR
SA

Shri. Pranav Amin (49)

Non-Executive Lead Independent Director

5.00 M INR
MN

Mr. Michael Neeb (62)

Non-Executive Independent Director

4.90 M INR
AB

Mr. Anil Bhatnagar (74)

Non-Executive Non-Independent Director

4.70 M INR
NS

Mr. Narayan Seshadri (68)

Non-Executive Non-Independent Director

4.50 M INR

Frequently asked questions about Max Healthcare Institute

The main competitors of Max Healthcare Institute Ltd in the market are Apollo Hospitals, Fortis Healthcare, and Manipal Hospitals.

The business model of Max Healthcare Institute Ltd revolves around providing comprehensive healthcare services in India. As a leading healthcare organization, Max Healthcare operates a network of hospitals and medical centers that offer a wide range of clinical specialties and advanced treatments. The company focuses on delivering quality healthcare services through state-of-the-art infrastructure, highly skilled medical professionals, and advanced technology. Max Healthcare follows a patient-centric approach and aims to provide personalized care to individuals across all age groups. By prioritizing patient comfort, safety, and well-being, Max Healthcare strives to be a trusted and preferred healthcare provider in the country.

Max Healthcare Institute Ltd is primarily active in the healthcare industry.

Max Healthcare Institute Ltd is a leading healthcare provider in India. Established in 2000, the company has a rich history of delivering high-quality medical services to patients across the country. Max Healthcare Institute Ltd operates a network of hospitals and specialized centers, offering a comprehensive range of medical treatments and facilities. With a commitment to clinical excellence and patient-centric care, the company has emerged as a trusted name in the healthcare industry. Max Healthcare Institute Ltd continues to expand its footprint and invest in advanced technologies to provide the best possible healthcare solutions to its patients.

Max Healthcare Institute Ltd has achieved several significant milestones in its journey. It has emerged as one of India's leading healthcare providers, offering world-class medical services. The company has consistently expanded its network of hospitals and healthcare centers across various cities, providing accessible and quality healthcare to a larger population. Max Healthcare Institute Ltd has been recognized for its commitment to patient care and clinical excellence, receiving prestigious accreditations and certifications. Moreover, it has successfully introduced advanced medical technologies and treatments, ensuring cutting-edge and comprehensive healthcare services. It continues to strive towards innovation, patient-centricity, and delivering the highest standards of healthcare, further strengthening its position in the industry.

Max Healthcare Institute Ltd is primarily present in India.

Max Healthcare Institute Ltd represents a strong set of values and a unique corporate philosophy. As a leading healthcare provider, the company is committed to delivering global standards of medical expertise, patient-centric care, and innovative technology. Max Healthcare Institute Ltd strives to provide comprehensive healthcare solutions while maintaining the highest ethical standards and fostering a culture of empathy and compassion. With an unwavering focus on safety, integrity, and excellence, the company aims to enhance well-being and deliver superior healthcare services to its patients. Max Healthcare Institute Ltd prides itself on its dedication to quality, collaboration, and continuous improvement, making it a trusted name in the healthcare industry.

Analysts currently set an average price target of 1,244.12 INR for the Max Healthcare Institute stock (median: 1,295.40 INR), implying +16.4 % versus the latest price. The consensus is based on 25 analyst ratings.

Max Healthcare Institute Analyst Price Targets 2026

26 analysts currently rate the Max Healthcare Institute stock: 19 recommend buying, 3 holding and 4 selling. For 2026, analysts expect Max Healthcare Institute to generate revenue of 101.88 B INR and earnings per share of 17.03 INR.

Max Healthcare Institute Analyst Price Targets 2026

Converted at the current exchange rate, the Max Healthcare Institute share trades at 9.71 EUR (1,069.00 INR).

Max Healthcare Institute Ltd is a leading healthcare company in India. The company operates in several divisions and offers a wide range of products and services to its customers. One of the main divisions of the company is the Max Hospitals Division, which operates 16 hospitals across India providing top-quality medical care in various specialties. Under the Max Labs Division, the company offers laboratory services including diagnostics and clinical tests. The Max Pharma Division is responsible for producing and distributing pharmaceutical products. The Max Clinics Division operates health centers and clinics offering various medical services. The Max Foundation is the company's social division, focused on improving healthcare in disadvantaged communities through free health camps and medical services. The company also provides health insurance and is involved in medical education and research. Overall, Max Healthcare Institute Ltd offers a wide range of products and services in the healthcare sector.

The expected revenue of Max Healthcare Institute is 101.88 B INR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Max Healthcare Institute is 16.64 B INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Max Healthcare Institute is currently 62.79. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Max Healthcare Institute stock.

The price-to-sales ratio (P/S) of Max Healthcare Institute is currently 10.26. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Max Healthcare Institute stock.

The Eulerpool Quality Score for Max Healthcare Institute is 5/10.

The ISIN of Max Healthcare Institute is INE027H01010. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Max Healthcare Institute is MAXHEALTH.NS. The ticker symbol is used to trade Max Healthcare Institute shares on the stock exchange.

Over the past 12 months, Max Healthcare Institute paid a dividend of 1.50 INR . This corresponds to a dividend yield of about 0.14 %. For the coming 12 months, Max Healthcare Institute is expected to pay a dividend of 1.80 INR.

The current dividend yield of Max Healthcare Institute is 0.14 %.

Max Healthcare Institute paid dividends every year for the past 3 years.

For the upcoming 12 months, dividends amounting to 1.80 INR are expected. This corresponds to a dividend yield of 0.17 %.

Max Healthcare Institute is assigned to the 'Health' sector.

To receive the latest dividend of Max Healthcare Institute from amounting to 1.5 INR, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Max Healthcare Institute distributed 1 INR as dividends.

The dividends of Max Healthcare Institute are distributed in INR.

All fundamentals and in-depth analysis of Max Healthcare Institute

Our stock analysis for Max Healthcare Institute stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Max Healthcare Institute. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Max Healthcare Institute Stock
Max Healthcare Institute Revenue→
Max Healthcare Institute Stock
Max Healthcare Institute Net Income→
Max Healthcare Institute Stock
Max Healthcare Institute P/E→
Max Healthcare Institute Stock
Max Healthcare Institute P/S→
Max Healthcare Institute Stock
Max Healthcare Institute EBIT→
Max Healthcare Institute Stock
Max Healthcare Institute Dividend→
Max Healthcare Institute Stock
Max Healthcare Institute Directors Dealings→
Max Healthcare Institute Stock
Max Healthcare Institute Stocks→
Max Healthcare Institute Stock
Max Healthcare Institute Market capitalization→
Max Healthcare Institute Stock
Max Healthcare Institute Debt→
Max Healthcare Institute Stock
Max Healthcare Institute Liabilities→
Max Healthcare Institute Stock
Max Healthcare Institute Equity→
Max Healthcare Institute Stock
Max Healthcare Institute AAQS→
Max Healthcare Institute Stock
Max Healthcare Institute Employees→
Max Healthcare Institute Stock
Max Healthcare Institute ROE→
Max Healthcare Institute Stock
Max Healthcare Institute ROA→
Max Healthcare Institute Stock
Max Healthcare Institute ROCE→
Max Healthcare Institute Stock
Max Healthcare Institute News→
Max Healthcare Institute Stock
Max Healthcare Institute Analyst Price Targets→

Health Stocks

Max IndiaMaven BrandsMaxCyteMauna Kea TechnologiesMaxWin International HoldingsMatricelfMay & Baker NigeriaMatinas BioPharma HoldingsMayinglong Pharmaceutical Group CoMATERNUS-Kliniken-Mayne Pharma GroupMaster Style PCLAll Stocks A–Z →